Scorpius Holdings (SCPX)
NYSE MKT:SCPX
Holding SCPX?
Track your performance easily

Scorpius Holdings (SCPX) Stock Price & Analysis

2,622 Followers

SCPX Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

SCPX FAQ

What was Scorpius Holdings’s price range in the past 12 months?
Scorpius Holdings lowest stock price was $0.70 and its highest was $110.00 in the past 12 months.
    What is Scorpius Holdings’s market cap?
    Currently, no data Available
    When is Scorpius Holdings’s upcoming earnings report date?
    Scorpius Holdings’s upcoming earnings report date is Nov 11, 2024 which is in 31 days.
      How were Scorpius Holdings’s earnings last quarter?
      Scorpius Holdings released its earnings results on Aug 20, 2024. The company reported -$26.98 earnings per share for the quarter, missing the consensus estimate of N/A by -$26.98.
        Is Scorpius Holdings overvalued?
        According to Wall Street analysts Scorpius Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Scorpius Holdings pay dividends?
          Scorpius Holdings does not currently pay dividends.
          What is Scorpius Holdings’s EPS estimate?
          Scorpius Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Scorpius Holdings have?
          Scorpius Holdings has 3,116,268 shares outstanding.
            What happened to Scorpius Holdings’s price movement after its last earnings report?
            Scorpius Holdings reported an EPS of -$26.98 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.526%.
              Which hedge fund is a major shareholder of Scorpius Holdings?
              Currently, no hedge funds are holding shares in SCPX
              ---

              Scorpius Holdings Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -99.29%
              12-Months-Change

              Fundamentals

              Return on Equity
              -79.55%
              Trailing 12-Months
              Asset Growth
              -41.77%
              Trailing 12-Months

              Company Description

              Scorpius Holdings

              Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              BioCryst
              Cormedix
              Kala Pharmaceuticals
              Medicinova
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis